Atlas Trials

A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Clinical trial NCT01851824 · COMPLETED

Trial details

NCT number
NCT01851824
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Melanoma, Neoplasms
Start date
2013-08-01
Primary completion
2014-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.